Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...

The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around ...

Biologic and conventional therapies were associated with comparable rates of cancer progression and recurrence among patients with psoriasis who have active cancer or who have had cancer within 5 ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...

The association of ctDNA with recurrence in patients with stage II-IV colorectal cancer: The β-CORRECT study. Phase II study of short-course radiotherapy (SCRT) followed by consolidation chemotherapy ...